CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty.  In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading ->
When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading ->
International NGOs and activists have called out the US for siding with China to exclude the public from seeing drafts of the pandemic accord as it is being negotiated by World Health Organization (WHO) member states. “The attempt to create a veil of secrecy now surrounding the substantive and technical text-based negotiations on the WHO […] Continue reading ->